The FDA has approved the first blood test to help detect Alzheimer’s disease. Developed by Fujirebio Diagnostics, the ...

"A suitable radiotracer that can noninvasively map synucleinopathies through PET imaging will lead to breakthroughs in early diagnosis, monitoring disease progression, and evaluating treatment ...

A ground-breaking procedure at the Royal Victoria Infirmary saw surgeons become the first in the UK to implant a new "pacemaker for the brain" to treat epilepsy. A team, led by Tyneside ...

MELBOURNE, Australia, April 29, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET 1 imaging agent ...

There is currently no FDA-approved targeted amino acid PET agent for brain cancer imaging available in the US. TLX101-CDx was previously granted Orphan Drug and Fast Track designations by the FDA.

A 19-year-old epilepsy patient, after undergoing brain-computer interface (BCI) surgery, not only realized brain-controlled operation of casual computer games but also demonstrated precise neural ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

More information: Kevin J. Chung et al, Quantitative PET imaging and modeling of molecular blood-brain barrier permeability, Nature Communications (2025). DOI: 10.1038/s41467-025-58356-7 ...

Shanghai Medical College and Center for Biomedical Imaging, Fudan University, Shanghai 200032, P.R. China Center for Biomedical imaging, Fudan University, Shanghai 200032, P.R. China Shanghai ...